(Q87269919)

English

Mature results of a phase II study of rituximab therapy for nodular lymphocyte-predominant Hodgkin lymphoma

scientific article published on 10 February 2014

In more languages
default for all languages
No label defined

No description defined

Statements

Mature results of a phase II study of rituximab therapy for nodular lymphocyte-predominant Hodgkin lymphoma (English)

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit